Mutation of PTEN was significantly different in five cancer types, among which the mutation rate of PTEN in ccRCC and PRAD was higher in metastatic cancer but lower in CRC, Glioma, and ENDO. Here, PTEN is linked to metastatic malignant neoplasm.